- DESCRIPTION
- TABLE OF CONTENTS
- METHODOLOGY
- DOWNLOAD PDF
Veterinary PoC Diagnostics Market by Product (Consumables and Instruments), Technology [Immunodiagnostics, Molecular Diagnostics (Isothermal Amplification, PCR, CRISPR)], Animal Type (Companion Animals, Livestock, Poultry) - Global Forecast to 2031
USD 1.72 BN
MARKET SIZE, 2031
VETERINARY POC DIAGNOSTICS MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global veterinary PoC diagnostics market is projected to grow from USD 1.19 billion in 2026 to USD 1.72 billion by 2031, at a CAGR of 7.7% during the forecast period. The market was valued at USD 1.10 billion in 2025. The veterinary PoC diagnostics market is expected to grow at a significant rate over the forecast period, owing to the rising incidences of animal diseases, coupled with increasing requirements for quick, on-site diagnosis and emphasis on early disease detection and preventive healthcare. The growth is also attributed to surging adoption of companion animals and intensification of livestock production. The market is further boosted by the deployment of cutting-edge PoC products such as rapid immunoassays, portable molecular diagnostic devices, and handheld analyzers, which provide better disease monitoring to enable swifter clinical decisions.
KEY TAKEAWAYS
-
By Region
Asia Pacific is estimated to register the highest CAGR of 9.0% in the veterinary PoC diagnostics market during the forecast period.
-
By Product
By product, the consumables segment accounted for a larger market share of 88.0% in 2025.
-
By Technology
By technology, the immunodiagnostics segment dominated the market with 84.7% share in 2025.
-
By Animal Type
By animal type, the companion animals segment accounted for a share of 72.5% in 2025.
-
Competitive Landscape - Key Players
IDEXX Laboratories, Inc.; Zoetis Services LLC; and Antech Diagnostics, Inc. were identified as some of the star players in the veterinary PoC diagnostics market, given their extensive global reach and comprehensive product portfolios.
-
Competitive Landscape - Startups/SMEs
Biopanda Reagents Ltd., SKYLA CORPORATION, Fluxergy Inc., among others, have distinguished themselves among startups and SMEs due to their specialized veterinary expertise and focused product capabilities.
The veterinary PoC diagnostics market continues to grow steadily in response to an increase in the incidence of animal diseases and the rising demand for fast and accurate on-site detection. Rising ownership of companion animals, large-scale production of livestock, and increasing awareness of animal health management and disease surveillance are also fueling the market growth. Furthermore, innovations in rapid testing, portable and user-friendly veterinary PoC devices and increased accessibility of veterinary testing and diagnostics are also boosting the penetration of veterinary PoC technologies and accelerating market growth.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The role of consumers' business veterinary PoC diagnostics market is driven by factors such as rising incidences of animal diseases; increasing need for quick, accurate and instant on-field testing; and advancements in portable diagnostics technologies. The point-of-care diagnostic kits, reagents, and handheld testing platforms are likely to be utilized by veterinary clinics and hospitals, livestock farm owners, veterinary practitioners, and animal health care business owners, who are looking for reliable, easy-to-use and high performance solutions to provide treatment decisions instantly. Increased requirements for faster turnaround, improved diagnostic outputs, low-cost testing and better animal health benefits are expected to influence purchase decision process of veterinary PoC diagnostics market substantially.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
OPPORTUNITIES
Impact
Level
-
Technological advancements in portable molecular diagnostics and biosensors
-
Growing adoption in emerging markets with expanding veterinary infrastructure
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The veterinary PoC diagnostics market is mainly driven by the high demand for rapid diagnostics at the point-of-care. Veterinarians and animal health providers are depending more on PoC diagnostics to allow quick decision-making on-site, minimizing delays in treatment and improving animal health. The need for faster and better diagnostics is also driven by the growing prevalence of infectious and chronic diseases, increasing adoption of companion animals, and the surging need to effectively look after the health of farm animals.
One of the most significant limitations in the veterinary PoC diagnostics market is that some of the PoC tests still lack the sensitivity and accuracy achieved by centralized lab-based diagnostics. Although the PoC solutions are faster and more convenient for the veterinarian, certain complex conditions may still require confirmatory testing in advanced laboratories, which limits their use in certain instances. This perceived gap in diagnostic precision can affect confidence among veterinary professionals and slow adoption, particularly in critical or high-stakes diagnostic scenarios.
Technological innovations within portable molecular diagnostics, biosensors and microfluidics present strong growth opportunities for veterinary PoC diagnostics. Technologies such as miniaturized PCR machines, isothermal amplification platforms and connected diagnostic platforms are modernizing usability, improving diagnostic performance and facilitating real-time result interpretation and data sharing. All of these technological innovations are broadening the scope of PoC applications in veterinary settings.
One of the key barriers for the veterinary PoC diagnostics market is the lack of uniform standards and variation in the regulatory frameworks across various regions. Variations in approval processes, quality standards and requirements for compliance could hinder the manufacturing process and delay the commercialization of the products. Variation in the standards and guidelines for the use of the PoC tests and the interpretation of results could also affect the accuracy and user confidence, thereby requiring the stakeholders to operate in a varied regulatory environment, ensuring uniform performance of the products.
VETERINARY POC DIAGNOSTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Offers in-clinic point-of-care analyzers and rapid diagnostic test kits for hematology, chemistry, urinalysis, and infectious diseases used directly in veterinary clinics | Enables real-time, highly accurate diagnostics during patient visits | Improvises clinical decision-making and workflow efficiency |
|
|
Provides VetScan point-of-care diagnostic analyzers and rapid tests for chemistry, hematology, and immunodiagnostics across companion and livestock animals | Delivers fast, actionable insights at the point of care with integrated systems that enhance productivity and treatment accuracy |
|
|
Develops in-clinic diagnostic analyzers, rapid tests, and cloud-based data platforms for hematology, immunodiagnostics, and imaging integration | Supports comprehensive in-house diagnostics with connected systems | Enables faster diagnosis and improved practice management |
|
|
Offers rapid diagnostic kits and PoC testing solutions for infectious diseases, parasitology, and routine screening in veterinary settings | Provides easy-to-use, clinic-friendly diagnostics that support preventive care and early disease detection |
|
|
Supplies portable PCR systems, reagents, and rapid testing kits adapted for veterinary PoC and near-patient applications | Ensures high-sensitivity molecular detection with scalable and reliable solutions suitable for both clinics and field use |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The veterinary PoC diagnostics ecosystem comprises interconnected stakeholders involved in the development, manufacturing, regulation, distribution, and use of rapid diagnostic solutions for animal health. It includes PoC device manufacturers, rapid test kit developers, molecular technology providers, reagent suppliers, and research institutions supporting innovation in portable diagnostics. Regulatory authorities and government agencies play a key role in product approvals, quality standards, and disease surveillance, particularly for zoonotic and economically significant diseases. Distributors ensure market access, while end users such as veterinary clinics, hospitals, livestock farms, and field veterinarians drive demand through routine testing, early disease detection, and immediate clinical decision-making. The ecosystem is shaped by rising demand for decentralized testing, technological advancements, and increasing focus on preventive animal healthcare.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The consumables segment holds a larger share of the veterinary PoC diagnostics market. This can be attributed to the wide use of consumables in routine diagnostic tests conducted in large volumes on a daily basis. Test kits, cartridges, strips, and reagent packs are important for every test, and therefore display an unending demand, unlike instrument purchases. The increasing in-clinic testing demand, rapid PoC kit acceptance, and increased focus on preventive animal healthcare are the major factors that drive the growth of the consumables segment. Moreover, the relatively lower price of consumables, ease-of-use of kits, and their acceptance in most of the PoC platforms help in the growth of this segment.
In 2025, immunodiagnostics dominated the market because these tests have penetration in various veterinary fields owing to its rapid in-clinic or in-field testing ability. Immunodiagnostic tests, particularly lateral flow and ELISA-based rapid in-clinic tests, are widely used to detect infectious and parasitic diseases and perform basic biomarker screening in companion animals and livestock. The cost effectiveness, simplicity, minimal sample preparation, rapid results, and the ability to be operated in a field or clinical setting are key contributors for their significant adoption.
The companion animals segment accounted for a larger share of the veterinary PoC diagnostics market due to the rising global pet population and increasing spending on pet healthcare. Pet owners are increasingly seeking rapid, in-clinic diagnostic solutions for early disease detection and immediate treatment decisions, driving the adoption of PoC testing in veterinary clinics and hospitals. Additionally, higher awareness of preventive care, frequent veterinary visits, and the availability of advanced diagnostic technologies for companion animals contribute to greater testing volumes, making this segment dominant in the market.
REGION
Asia Pacific to be fastest-growing veterinary PoC diagnostics market during forecast period
Asia Pacific is likely to record the highest CAGR in the veterinary PoC diagnostics market during the forecast period, due to the rapid growth of the livestock industry, rising pet ownership, and the need for cost-effective diagnostic solutions. The improvement in the veterinary infrastructure and the shift toward decentralized, field-based testing in developing countries such as China and India is driving the adoption of portable diagnostic technologies. Factors such as the rising incidence of infectious and zoonotic diseases, government surveillance programs and the increasing expenditure for animal care are further propelling the penetration of advanced PoC diagnostic solutions in this region.
VETERINARY POC DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX
Within the veterinary PoC diagnostics market matrix, IDEXX Laboratories, Inc. (Star) is a dominant player, primarily supported by its comprehensive portfolio of in-clinic analyzers, rapid immunoassays, and integrated diagnostic platforms. Its leadership is reinforced by advanced point-of-care systems that deliver fast, accurate results during patient visits, along with strong digital integration. Bio-Rad Laboratories, Inc. (Emerging Leader) is strengthening its position through its robust expertise in molecular diagnostics, immunoassays, and life science research technologies, which are increasingly being adapted for veterinary applications. Its expanding diagnostic capabilities and focus on high-quality assay development are contributing to its growing presence in the veterinary PoC diagnostics market.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- IDEXX Laboratories, Inc. (US)
- Zoetis Services LLC (US)
- Antech Diagnostics, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- Virbac (France)
- bioMérieux (France)
- Neogen Corporation (US)
- INDICAL BIOSCIENCE GmbH (Germany)
- FUJIFILM Corporation (Japan)
- Enalees (France)
- EUROLyser Diagnostica GmbH (Austria)
- Bio-Rad Laboratories, Inc. (US)
- BioNote (South Korea)
- Shenzhen Mindray Animal Medical Technology Co., LTD. (China)
- Woodley Equipment Company Ltd (UK)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 1.10 Billion |
| Market Size in 2026 (Value) | USD 1.19 Billion |
| Market Size in 2031 (Value) | USD 1.72 Billion |
| CAGR | CAGR of 7.7% from 2026-2031 |
| Years Considered | 2024-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD Billion), Volume (Thousand Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
WHAT IS IN IT FOR YOU: VETERINARY POC DIAGNOSTICS MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | Comparative analysis of key veterinary PoC diagnostic product categories, including rapid lateral flow assays, portable molecular diagnostic devices, handheld analyzers, and cartridge-based systems. Highlighted technology trends such as miniaturization, multiplex testing, connectivity integration, and improvements in sensitivity and turnaround time, along with differentiation across major manufacturers. | Enabled identification of high-demand testing areas, technology adoption trends, pricing dynamics, and product positioning strategies to support portfolio expansion and competitive benchmarking |
| Company Information | Profiled key players including IDEXX Laboratories, Zoetis, Thermo Fisher Scientific, Antech, Virbac, Neogen, and Mindray Animal Medical. Provided insights on PoC product portfolios, technological capabilities, geographic presence, and strategic focus areas such as innovation, partnerships, and digital integration. | Delivered clarity on partnership and acquisition opportunities, competitive positioning, and investment hotspots influencing growth in the veterinary PoC diagnostics market |
| Geographic Analysis | Provided detailed analysis on Rest of APAC for veterinary PoC diagnostic demand. Assessed region-specific factors such as veterinary infrastructure, pet ownership trends, livestock population, disease prevalence, regulatory frameworks, and adoption of decentralized testing solutions. | Supported regional expansion strategies by identifying high-growth markets, demand drivers, localization opportunities, and distribution partnerships to accelerate adoption of PoC diagnostic technologies |
RECENT DEVELOPMENTS
- April 2026 : Zoetis enhanced its Vetscan OptiCell point-of-care hematology analyzer by adding new parameters, including CHCM and PCT, enabling deeper in-clinic diagnostics and more advanced real-time blood analysis.
- June 2025 : bioMérieux launched VETFIRE, a ready-to-use PCR kit specifically made for equine infectious respiratory diseases. It helps in the simultaneous detection of seven infectious respiratory pathogens in horses.
- March 2025 : Antech Diagnostics introduced the truRapid FOUR. It is an in-house canine vector-borne disease (CVBD) screening test. It will help detect canine antibodies to Anaplasma spp., Ehrlichia spp., Lyme C6 (Borrelia burgdorferi), and heartworm (Dirofilaria immitis) antigen.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
4
MARKET OVERVIEW
48
4.2.1.1
RISING INCIDENCE OF TRANSBOUNDARY AND ENDEMIC DISEASES
4.2.1.2
INCREASING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS
4.2.1.3
TECHNOLOGICAL ADVANCEMENTS IN MOLECULAR DIAGNOSTICS, MULTIPLEX ASSAYS, AND RAPID TESTING PLATFORMS
4.2.1.4
GROWTH IN COMPANION ANIMAL POPULATION
4.2.1.5
RISING DEMAND FOR PET INSURANCE AND GROWING ANIMAL HEALTH EXPENDITURE
4.2.2.1
RISING PET CARE COSTS
4.2.2.2
HIGH COST OF VETERINARY DIAGNOSTIC TESTS
4.2.2.3
LIMITED DIAGNOSTIC INFRASTRUCTURE IN EMERGING ECONOMIES
4.2.3.1
INTEGRATION OF AI & ML IN VETERINARY POC DIAGNOSTICS
4.2.3.2
EXPANSION OF RAPID POC AND PORTABLE ON-FARM DIAGNOSTIC SOLUTIONS
4.2.4.1
RAPID MUTATION AND STRAIN VARIABILITY OF VIRAL PATHOGENS
4.3
UNMET NEEDS AND WHITE SPACES
4.3.1
UNMET NEEDS IN VETERINARY POC DIAGNOSTICS MARKET
4.3.2
WHITE SPACE OPPORTUNITIES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1
INTERCONNECTED MARKETS
4.4.2
CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
4.5.1
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
5
INDUSTRY TRENDS
61
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
THREAT OF SUBSTITUTES
5.1.3
BARGAINING POWER OF SUPPLIERS
5.1.4
BARGAINING POWER OF BUYERS
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN GLOBAL HEALTHCARE INDUSTRY
5.2.4
TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY
5.5.1
PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023–2025
5.5.1.1
PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023−2025
5.5.2
PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY REGION, 2023–2025
5.5.2.1
PRICING TREND OF PCR KITS, BY REGION, 2023−2025
5.5.2.2
PRICING TREND OF IMMUNODIAGNOSTIC VETERINARY POC PRODUCTS, BY REGION, 2023−2025
5.6.1
TRADE DATA FOR HS CODE 3822-COMPLIANT PRODUCTS
5.6.1.1
COUNTRY-WISE IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, 2021–2025
5.6.1.2
COUNTRY-WISE EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, 2021–2025
5.7
KEY CONFERENCES AND EVENTS, 2026–2027
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.10.1
USE OF AI-POWERED POULTRY DISEASE DIAGNOSTICS FOR COCCIDIOSIS & SALMONELLA DETECTION
5.10.2
ADOPTION OF AI-ENABLED POC DIAGNOSTIC PLATFORM FOR PARASITE DETECTION
5.10.3
DEVELOPMENT OF SNAP 4DX PLUS TEST FOR RAPID VECTOR-BORNE DISEASE DETECTION
5.11
IMPACT OF US TARIFFS ON VETERINARY POC DIAGNOSTICS MARKET
5.11.3
PRICE IMPACT ANALYSIS
5.11.4
IMPACT ON COUNTRY/REGION
5.11.5
IMPACT ON END USERS
5.11.5.1
VETERINARY HOSPITALS & CLINICS
5.11.5.2
LIVESTOCK PRODUCERS & ANIMAL HEALTH NETWORKS
5.11.5.3
HOME CARE SETTINGS
5.11.5.4
OTHER END USERS (MOBILE VETERINARY SERVICE PROVIDERS, ANIMAL SHELTERS, NGOS)
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
83
6.1
KEY/EMERGING TECHNOLOGIES
6.1.1
CRISPR-BASED MOLECULAR DIAGNOSTICS
6.1.2
ISOTHERMAL AMPLIFICATION AND PAPER-BASED LAMP
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
MICROFLUIDICS & LAB-ON-A-CHIP DEVICES
6.2.2
BIOSENSOR-BASED DIAGNOSTIC SYSTEMS
6.3
ADJACENT TECHNOLOGIES
6.3.1
AI & MACHINE LEARNING
6.3.2
WEARABLE BIOSENSORS & REMOTE MONITORING DEVICES
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.4.1
NEAR TERM (2025–2027)
6.4.2
MID TERM (2028–2030)
6.5.1
PATENT PUBLICATION TRENDS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
6.5.2
JURISDICTION AND TOP APPLICANT ANALYSIS
6.6.1
PRECISION FLOCK-LEVEL DISEASE PREDICTION
6.6.2
MINI FULLY INTEGRATED ON-FARM MOLECULAR TESTING PLATFORMS
6.6.3
MULTIPLEX AND SYNDROMIC VETERINARY DIAGNOSTIC PANELS
6.6.4
SMART BIOSENSOR-ENABLED REAL-TIME HEALTH MONITORING
6.7
IMPACT OF AI/GENERATIVE AI ON VETERINARY POC DIAGNOSTICS MARKET
6.7.2
MARKET POTENTIAL IN VETERINARY POC DIAGNOSTIC ECOSYSTEM
6.7.4
KEY COMPANIES IMPLEMENTING AI IN VETERINARY POC DIAGNOSTICS MARKET
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
94
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY ANALYSIS
7.1.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY INITIATIVES
7.2.1
RECYCLED AND ECO-FRIENDLY MATERIALS FOR VETERINARY POC DIAGNOSTIC PRODUCTS
7.2.2
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
7.2.3
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
100
8.1
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1.1
DECISION-MAKING PROCESS
8.2
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.3.1
UNMET NEEDS OF VARIOUS END USERS
9
VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT
106
9.2.1
INCREASING PREVALENCE OF INFECTIOUS AND ZOONOTIC DISEASES IN ANIMALS TO BOOST DEMAND
9.2.2
GLOBAL VOLUME ANALYSIS OF CONSUMABLES, 2024–2031 (THOUSAND UNITS)
9.3.1
SURGING DEMAND FOR PORTABLE AND AUTOMATED DIAGNOSTIC SYSTEMS TO ACCELERATE MARKET GROWTH
9.3.2
GLOBAL VOLUME ANALYSIS OF INSTRUMENTS, 2024–2031 (THOUSAND UNITS)
10
VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE
115
10.2.1
GROWING PET ADOPTION DUE TO RISING URBANIZATION TO FACILITATE MARKET GROWTH
10.2.2.1
INCREASING PREVALENCE OF CANINE INFECTIOUS DISEASES TO SUPPORT RAPID ADOPTION OF VETERINARY CARE
10.2.3.1
GROWING AWARENESS OF FELINE INFECTIOUS DISEASES TO FUEL MARKET GROWTH
10.2.4.1
NEED TO PREVENT VERTICAL PATHOGEN TRANSMISSION TO STIMULATE USE OF EXTENSIVE PCR SURVEILLANCE SOLUTIONS
10.2.5
OTHER COMPANION ANIMALS
10.3.1
SUSCEPTIBILITY OF LIVESTOCK TO FOOT-AND-MOUTH DISEASE, CLASSICAL SWINE FEVER, AVIAN INFLUENZA TO PROMOTE ADOPTION OF DIAGNOSTIC PRODUCTS
10.3.2.1
INCREASING FOCUS ON IMPROVING MILK QUALITY, HERD PRODUCTIVITY, AND BIOSECURITY MANAGEMENT TO DRIVE DEMAND
10.3.3.1
GROWING SWINE DISEASE OUTBREAKS TO ACCELERATE DIAGNOSTIC UTILIZATION
10.3.4.1
RRISING CONCERNS REGARDING ZOONOTIC DISEASE TRANSMISSION TO SPUR DEMAND
11
VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY
135
11.2.1
PRESSING NEED FOR RAPID AND COST-EFFECTIVE INFECTIOUS DISEASE TESTING TO CONTRIBUTE TO MARKET GROWTH
11.3
MOLECULAR DIAGNOSTICS
11.3.1.1
INCREASING USE OF PORTABLE AND MULTIPLEX PCR PLATFORMS TO PROPEL MARKET
11.3.2
ISOTHERMAL AMPLIFICATION
11.3.2.1
DEMAND FOR RAPID AND LOW-INFRASTRUCTURE MOLECULAR TESTING TO ACCELERATE ADOPTION
11.3.3.1
EMERGING NEXT-GENERATION PATHOGEN DETECTION TECHNOLOGIES TO CREATE GROWTH POTENTIAL
12
VETERINARY POC DIAGNOSTICS MARKET, BY REGION
148
12.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2
NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.2.3.1
HIGH VETERINARY HEALTHCARE EXPENDITURE TO DRIVE MARKET
12.2.4.1
GROWING PET ADOPTION TO DRIVE MARKET
12.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2
EUROPE: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.3.3.1
RISING AWARENESS OF ZOONOTIC DISEASES TO FUEL MARKET GROWTH
12.3.4.1
INCREASING PET OWNERSHIP TO STIMULATE DEMAND
12.3.5.1
WILLINGNESS OF PET OWNERS TO SPEND ON PET HEALTH TO PROMOTE MARKET GROWTH
12.3.6.1
GROWING CONSUMPTION OF MEAT AND DAIRY PRODUCTS TO DRIVE MARKET
12.3.7.1
GROWING DEMAND FOR POULTRY PRODUCTS TO FUEL MARKET GROWTH
12.3.8.1
DEVELOPMENTS IN VETERINARY DIAGNOSTIC PRODUCTS TO SUPPORT MARKET GROWTH
12.3.9.1
RAPID EXPANSION OF POULTRY PRODUCTION AND EXPORT-ORIENTED FARMING TO ELEVATE DEMAND
12.3.10.1
STRONG VETERINARY HEALTHCARE INFRASTRUCTURE AND ADVANCED ANIMAL WELFARE REGULATIONS TO PROPEL MARKET
12.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2
ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.4.3.1
INCREASING INCIDENCE OF ZOONOTIC DISEASES TO PROPEL MARKET
12.4.4.1
INCREASING PET EXPENDITURE TO SUPPORT MARKET GROWTH
12.4.5.1
INCREASING DEMAND FOR DAIRY PRODUCTS TO DRIVE MARKET
12.4.6.1
RISE IN PET OWNERSHIP TO SUPPORT MARKET GROWTH
12.4.7.1
RISING NEED FOR SPECIALIZED VETERINARY SERVICES TO DRIVE MARKET
12.4.8.1
FOCUS ON PET INSURANCE TO AID MARKET
12.4.9.1
GROWING FOCUS ON DISEASE SURVEILLANCE TO DRIVE MARKET
12.4.10
REST OF ASIA PACIFIC
12.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2
LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.5.3.1
BOOMING LIVESTOCK INDUSTRY TO BOOST DEMAND
12.5.4.1
EXPANDING POULTRY SECTOR TO SUPPORT MARKET GROWTH
12.5.5.1
EXPANDING POULTRY PRODUCTION AND INCREASING FOCUS ON DISEASE MONITORING TO DRIVE MARKET
12.5.6
REST OF LATIN AMERICA
12.6
MIDDLE EAST & AFRICA
12.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2
MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.6.3.1
KINGDOM OF SAUDI ARABIA (KSA)
12.6.3.1.1
TECHNOLOGY ADVANCEMENTS IN VETERINARY DIAGNOSTICS TO BOOST DEMAND
12.6.3.2
UNITED ARAB EMIRATES (UAE)
12.6.3.2.1
FAVORABLE GOVERNMENT SUPPORT FOR VET DIAGNOSTICS TO DRIVE MARKET
12.6.3.3
REST OF GCC COUNTRIES
12.6.4
REST OF MIDDLE EAST & AFRICA
13
COMPETITIVE LANDSCAPE
253
13.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, JANUARY 2022–APRIL 2026
13.3
REVENUE ANALYSIS, 2021−2025
13.4
MARKET SHARE ANALYSIS, 2025
13.4.1
US MARKET SHARE ANALYSIS, 2025
13.4.2
EUROPE MARKET SHARE ANALYSIS, 2025
13.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
13.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.5.5.1
COMPANY FOOTPRINT
13.5.5.2
REGION FOOTPRINT
13.5.5.3
PRODUCT FOOTPRINT
13.5.5.4
TECHNOLOGY FOOTPRINT
13.5.5.5
ANIMAL TYPE FOOTPRINT
13.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.6.1
PROGRESSIVE COMPANIES
13.6.2
RESPONSIVE COMPANIES
13.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
13.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.7
BRAND/PRODUCT COMPARISON
13.8
R&D EXPENDITURE OF KEY PLAYERS
13.9
COMPANY VALUATION AND FINANCIAL METRICS
13.10
COMPETITIVE SCENARIO
13.10.1
PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
13.10.4
OTHER DEVELOPMENTS
14
COMPANY PROFILES
277
14.1.1
IDEXX LABORATORIES, INC.
14.1.1.1
BUSINESS OVERVIEW
14.1.1.2
PRODUCTS OFFERED
14.1.1.3
RECENT DEVELOPMENTS
14.1.1.3.1
PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
14.1.1.4.2
STRATEGIC CHOICES
14.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
14.1.2
ZOETIS SERVICES LLC
14.1.3
THERMO FISHER SCIENTIFIC INC.
14.1.4
ANTECH DIAGNOSTICS, INC.
14.1.6
INNOVATIVE DIAGNOSTICS
14.1.8
INDICAL BIOSCIENCE GMBH
14.1.10
MEGACOR DIAGNOSTIK GMBH
14.1.12
RING BIOTECHNOLOGY CO., LTD.
14.1.15
BIOPANDA REAGENTS LTD
14.2.3
GOLD STANDARD DIAGNOSTICS
14.2.4
BIO-X DIAGNOSTICS S.A.
14.2.6
ALVEO TECHNOLOGIES
14.2.8
WOODLEY EQUIPMENT COMPANY LTD
14.2.9
UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD.
15
RESEARCH METHODOLOGY
348
15.2
RESEARCH METHODOLOGY DESIGN
15.2.1
SECONDARY RESEARCH
15.2.1.1
KEY DATA FROM SECONDARY SOURCES
15.2.2.1
KEY DATA FROM PRIMARY SOURCES
15.2.2.2
KEY INDUSTRY INSIGHTS
15.3
MARKET SIZE ESTIMATION
15.3.1
BOTTOM-UP APPROACH
15.5
MARKET SHARE ESTIMATION
15.6
RESEARCH ASSUMPTIONS
15.7
RESEARCH LIMITATIONS
15.7.1
METHODOLOGY-RELATED LIMITATIONS
15.7.2
SCOPE-RELATED LIMITATIONS
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
CUSTOMIZATION OPTIONS
16.3.2
COMPANY INFORMATION
16.3.3
GEOGRAPHIC ANALYSIS
16.3.4
REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
16.3.5
COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT TYPE
16.3.6
BY PRODUCT TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
16.3.7
ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
TABLE 1
STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
TABLE 2
NUMBER OF US HOUSEHOLDS OWNING PETS, BY ANIMAL TYPE, 2024 (MILLION)
TABLE 3
VETERINARY POC DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4
GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION)
TABLE 5
PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023–2025
TABLE 6
PRICING TREND OF PCR KITS, BY REGION, 2023−2025
TABLE 7
PRICING TREND OF IMMUNODIAGNOSTIC (RAPID TEST) VETERINARY POC PRODUCTS, BY REGION, 2023−2025
TABLE 8
IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 9
EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 10
VETERINARY POC DIAGNOSTICS MARKET: MAJOR CONFERENCES AND EVENTS IN 2026–2027
TABLE 11
CASE STUDY 1: ADVANCED DIAGNOSTIC SOLUTIONS FOR POULTRY DISEASES: TARGETING COCCIDIOSIS AND SALMONELLA DETECTION USING AI TECHNOLOGIES
TABLE 12
CASE STUDY 2: AI-POWERED DIAGNOSTIC PLATFORM WITH DIGITAL MICROSCOPY AND DEEP LEARNING: TARGETING PARASITE DETECTION
TABLE 13
CASE STUDY 3: MULTIPLEX ELISA-BASED POC DIAGNOSTIC TEST: TARGETING VECTOR-BORNE DISEASE DETECTION
TABLE 14
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 15
KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR VETERINARY POC DIAGNOSTIC PRODUCTS
TABLE 16
NORTH AMERICA: IMPACT OF US TARIFFS ON CANADA
TABLE 17
ASIA PACIFIC: IMPACT OF US TARIFFS ON CHINA, JAPAN, AND INDIA
TABLE 18
EUROPE: IMPACT OF US TARIFFS ON GERMANY AND UK
TABLE 19
LATIN AMERICA: IMPACT OF US TARIFFS ON MEXICO
TABLE 20
VETERINARY POC DIAGNOSTICS MARKET: MAJOR PATENTS
TABLE 21
KEY COMPANIES ADOPTING AI-POWERED VETERINARY POC DIAGNOSTIC PRODUCTS
TABLE 22
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 27
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY POC DIAGNOSTIC PRODUCTS
TABLE 28
KEY BUYING CRITERIA FOR TOP 3 END USERS
TABLE 29
VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 30
VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 31
KEY PLAYERS PROVIDING CONSUMABLES
TABLE 32
CONSUMABLES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 33
CONSUMABLES: VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS)
TABLE 34
KEY PLAYERS PROVIDING INSTRUMENTS
TABLE 35
INSTRUMENTS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36
INSTRUMENTS: VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS)
TABLE 37
VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 38
KEY PLAYERS PROVIDING VETERINARY POC DIAGNOSTICS FOR COMPANION ANIMALS
TABLE 39
COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 40
COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41
DOG: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42
CAT: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43
HORSE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44
OTHER COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45
KEY PLAYERS PROVIDING VETERINARY POC DIAGNOSTICS FOR LIVESTOCK
TABLE 46
LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 47
LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48
CATTLE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49
PIG: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50
POULTRY: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51
OTHER LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52
VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 53
KEY PLAYERS PROVIDING IMMUNODIAGNOSTICS
TABLE 54
IMMUNODIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55
KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS
TABLE 56
MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 57
MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58
PCR-BASED MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59
ISOTHERMAL AMPLIFICATION MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60
CRISPR-BASED MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61
OTHER TECHNOLOGIES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62
GLOBAL VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 63
NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 64
NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65
NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 66
NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 67
NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 68
NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 69
NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 70
NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 71
US: KEY MACRO INDICATORS
TABLE 72
US: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 73
US: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 74
US: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 75
US: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 76
US: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 77
US: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 78
CANADA: KEY MACRO INDICATORS
TABLE 79
CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 80
CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 81
CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 82
CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 83
CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 84
CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 85
EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 86
EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87
EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 88
EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 89
EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 90
EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 91
EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 92
EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 93
GERMANY: KEY MACRO INDICATORS
TABLE 94
GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 95
GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 96
GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 97
GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 98
GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 99
GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 100
UK: KEY MACRO INDICATORS
TABLE 101
UK: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 102
UK: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 103
UK: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 104
UK: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 105
UK: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 106
UK: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 107
FRANCE: KEY MACRO INDICATORS
TABLE 108
FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 109
FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 110
FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 111
FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 112
FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 113
FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 114
ITALY: KEY MACRO INDICATORS
TABLE 115
ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 116
ITALY VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 117
ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 118
ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 119
ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 120
ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 121
SPAIN: KEY MACRO INDICATORS
TABLE 122
SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 123
SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 124
SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 125
SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 126
SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 127
SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 128
NETHERLANDS: KEY MACRO INDICATORS
TABLE 129
NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 130
NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 131
NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 132
NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 133
NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 134
NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 135
POLAND: KEY MACRO INDICATORS
TABLE 136
POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 137
POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 138
POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 139
POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 140
POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 141
POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 142
SWEDEN: KEY MACRO INDICATORS
TABLE 143
SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 144
SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 145
SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 146
SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 147
SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 148
SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 149
REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 150
REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 151
REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 152
REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 153
REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 154
REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 155
ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 156
ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157
ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 158
ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 159
ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 160
ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 161
ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 162
ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 163
CHINA: KEY MACRO INDICATORS
TABLE 164
CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 165
CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 166
CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 167
CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 168
CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 169
CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 170
JAPAN: KEY MACRO INDICATORS
TABLE 171
JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 172
JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 173
JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 174
JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 175
JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 176
JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 177
INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
TABLE 178
INDIA: KEY MACRO INDICATORS
TABLE 179
INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 180
INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 181
INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 182
INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 183
INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 184
INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 185
AUSTRALIA: KEY MACRO INDICATORS
TABLE 186
AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 187
AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 188
AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 189
AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 190
AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 191
AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 192
SOUTH KOREA: KEY MACRO INDICATORS
TABLE 193
SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 194
SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 195
SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 196
SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 197
SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 198
SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 199
NEW ZEALAND: KEY MACRO INDICATORS
TABLE 200
NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 201
NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 202
NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 203
NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 204
NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 205
NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 206
THAILAND: KEY MACRO INDICATORS
TABLE 207
THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 208
THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 209
THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 210
THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 211
THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 212
THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 213
REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 214
REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 215
REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 216
REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 217
REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 218
REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 219
LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 220
LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 221
LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 222
LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 223
LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 224
LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 225
LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 226
LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 227
BRAZIL: KEY MACRO INDICATORS
TABLE 228
BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 229
BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 230
BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 231
BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 232
BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 233
BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 234
MEXICO: KEY MACRO INDICATORS
TABLE 235
MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 236
MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 237
MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 238
MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 239
MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 240
MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 241
ARGENTINA: KEY MACRO INDICATORS
TABLE 242
ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 243
ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 244
ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 245
ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 246
ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 247
ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 248
REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 249
REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 250
REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 251
REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 252
REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 253
REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 254
MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 255
MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 256
MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 257
MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 258
MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 259
MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 260
MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 261
MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 262
GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 263
GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 264
GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 265
GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 266
GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 267
GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 268
GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 269
KINGDOM OF SAUDI ARABIA (KSA): KEY MACRO INDICATORS
TABLE 270
KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 271
KINGDOM OF SAUDI ARABIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 272
KINGDOM OF SAUDI ARABIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 273
KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 274
KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 275
KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 276
UNITED ARAB EMIRATES (UAE): KEY MACRO INDICATORS
TABLE 277
UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 278
UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 279
UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 280
UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 281
UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 282
UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 283
REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 284
REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 285
REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 286
REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 287
REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 288
REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 289
REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 290
REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 291
REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 292
REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 293
REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 294
REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 295
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET
TABLE 296
VETERINARY POC DIAGNOSTICS MARKET: DEGREE OF COMPETITION
TABLE 297
US VETERINARY POC DIAGNOSTICS MARKET: DEGREE OF COMPETITION
TABLE 298
EUROPE VETERINARY POC DIAGNOSTICS MARKET: DEGREE OF COMPETITION
TABLE 299
VETERINARY POC DIAGNOSTICS MARKET: REGION FOOTPRINT
TABLE 300
VETERINARY POC DIAGNOSTICS MARKET: PRODUCT FOOTPRINT
TABLE 301
VETERINARY POC DIAGNOSTICS MARKET: TECHNOLOGY FOOTPRINT
TABLE 302
VETERINARY POC DIAGNOSTICS MARKET: ANIMAL TYPE FOOTPRINT
TABLE 303
VETERINARY POC DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 304
VETERINARY POC DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
TABLE 305
VETERINARY POC DIAGNOSTICS MARKET: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS, JANUARY 2022–MAY 2026
TABLE 306
VETERINARY POC DIAGNOSTICS MARKET: DEALS, JANUARY 2022–APRIL 2026
TABLE 307
VETERINARY POC DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2022–APRIL 2026
TABLE 308
VETERINARY POC DIAGNOSTICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2026
TABLE 309
IDEXX LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 310
IDEXX LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 311
IDEXX LABORATORIES, INC.: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
TABLE 312
ZOETIS SERVICES LLC: COMPANY OVERVIEW
TABLE 313
ZOETIS SERVICES LLC: PRODUCTS OFFERED
TABLE 314
ZOETIS SERVICES LLC: DEALS
TABLE 315
ZOETIS SERVICES LLC: EXPANSIONS
TABLE 316
ZOETIS SERVICES LLC: OTHER DEVELOPMENTS
TABLE 317
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 318
THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 319
ANTECH DIAGNOSTICS, INC.: COMPANY OVERVIEW
TABLE 320
ANTECH DIAGNOSTICS, INC.: PRODUCTS OFFERED
TABLE 321
ANTECH DIAGNOSTICS, INC.: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
TABLE 322
ANTECH DIAGNOSTICS, INC.: EXPANSIONS
TABLE 323
BIONOTE: COMPANY OVERVIEW
TABLE 324
BIONOTE: PRODUCTS OFFERED
TABLE 325
BIONOTE: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
TABLE 327
INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW
TABLE 328
INNOVATIVE DIAGNOSTICS: PRODUCTS OFFERED
TABLE 329
INNOVATIVE DIAGNOSTICS: OTHER DEVELOPMENTS
TABLE 330
BIOMÉRIEUX: COMPANY OVERVIEW
TABLE 331
BIOMÉRIEUX: PRODUCTS OFFERED
TABLE 332
BIOMÉRIEUX: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
TABLE 333
INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW
TABLE 334
INDICAL BIOSCIENCE GMBH: PRODUCTS OFFERED
TABLE 335
INDICAL BIOSCIENCE GMBH: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
TABLE 336
VIRBAC: COMPANY OVERVIEW
TABLE 337
VIRBAC: PRODUCTS OFFERED
TABLE 339
VIRBAC: EXPANSIONS
TABLE 340
MEGACOR DIAGNOSTIK GMBH: COMPANY OVERVIEW
TABLE 341
MEGACOR DIAGNOSTIK GMBH: PRODUCTS OFFERED
TABLE 342
MEGACOR DIAGNOSTIK GMBH: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
TABLE 343
BIOGAL: COMPANY OVERVIEW
TABLE 344
BIOGAL: PRODUCTS OFFERED
TABLE 345
RING BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 346
RING BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED
TABLE 347
RING BIOTECHNOLOGY CO., LTD.: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
TABLE 348
RING BIOTECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS
TABLE 349
AGROLABO S.P.A.: COMPANY OVERVIEW
TABLE 350
AGROLABO S.P.A.: PRODUCTS OFFERED
TABLE 351
ENALEES: COMPANY OVERVIEW
TABLE 352
ENALEES: PRODUCTS OFFERED
TABLE 353
ENALEES: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
TABLE 355
ENALEES: EXPANSIONS
TABLE 356
ENALEES: OTHER DEVELOPMENTS
TABLE 357
BIOPANDA REAGENTS LTD: COMPANY OVERVIEW
TABLE 358
BIOPANDA REAGENTS LTD: PRODUCTS OFFERED
TABLE 359
FASSISI, GMBH: COMPANY OVERVIEW
TABLE 360
SKYER, INC.: COMPANY OVERVIEW
TABLE 361
GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW
TABLE 362
BIO-X DIAGNOSTICS S.A.: COMPANY OVERVIEW
TABLE 363
AFFIGEN INC.: COMPANY OVERVIEW
TABLE 364
ALVEO TECHNOLOGIES: COMPANY OVERVIEW
TABLE 365
FLUXERGY INC.: COMPANY OVERVIEW
TABLE 366
WOODLEY EQUIPMENT COMPANY LTD: COMPANY OVERVIEW
TABLE 367
UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD.: COMPANY OVERVIEW
TABLE 368
CORIS BIOCONCEPT: COMPANY OVERVIEW
TABLE 369
VETERINARY POC DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS
TABLE 370
VETERINARY POC DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS
FIGURE 1
VETERINARY POC DIAGNOSTICS MARKET SEGMENTATION AND REGIONAL SCOPE
FIGURE 3
GLOBAL VETERINARY POC DIAGNOSTICS MARKET, 2024–2031
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET, 2020–2025
FIGURE 5
DISRUPTIONS INFLUENCING GROWTH OF VETERINARY POC DIAGNOSTICS MARKET
FIGURE 6
HIGH-GROWTH SEGMENTS IN VETERINARY POC DIAGNOSTICS MARKET, 2026–2031
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN VETERINARY POC DIAGNOSTICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 8
INCREASING DEMAND FOR RAPID AND ON-SITE DIAGNOSTICS TO FUEL MARKET GROWTH
FIGURE 9
CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
FIGURE 10
ASIA PACIFIC TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 11
CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 12
EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 13
VETERINARY POC DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14
PET EXPENDITURE IN US, DOGS VS. CATS, 2024 (USD)
FIGURE 15
VETERINARY POC DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 16
VETERINARY POC DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
FIGURE 17
VETERINARY POC DIAGNOSTIC ECOSYSTEM ANALYSIS
FIGURE 18
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 19
VETERINARY POC DIAGNOSTICS MARKET: INVESTMENT AND FUNDING SCENARIO
FIGURE 20
VETERINARY POC DIAGNOSTICS MARKET: NUMBER OF PATENTS GRANTED AND APPLIED (JANUARY 2015–MAY 2026)
FIGURE 21
TOP APPLICANT COUNTRIES AND REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2015–FEBRUARY 2026)
FIGURE 22
ADOPTION OF AI-POWERED DIAGNOSTIC SOLUTIONS FOR DISEASE TREND IDENTIFICATION AND TREATMENT OPTIMIZATION
FIGURE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY POC DIAGNOSTIC PRODUCTS
FIGURE 24
KEY BUYING CRITERIA FOR TOP 3 END USERS
FIGURE 25
VETERINARY POC DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 26
EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA, 2012–2030
FIGURE 27
NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET SNAPSHOT
FIGURE 28
ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 29
ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 30
ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET SNAPSHOT
FIGURE 31
REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2021−2025)
FIGURE 32
MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025)
FIGURE 33
US MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025)
FIGURE 34
EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025)
FIGURE 35
VETERINARY POC DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 36
VETERINARY POC DIAGNOSTICS MARKET: COMPANY FOOTPRINT
FIGURE 37
VETERINARY POC DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 38
VETERINARY POC DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 39
R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET, 2022−2025
FIGURE 40
EV/EBITDA OF KEY VENDORS
FIGURE 41
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 42
IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 43
ZOETIS SERVICES LLC: COMPANY SNAPSHOT
FIGURE 44
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 45
BIOMÉRIEUX: COMPANY SNAPSHOT
FIGURE 46
VIRBAC: COMPANY SNAPSHOT
FIGURE 47
VETERINARY POC DIAGNOSTICS MARKET: RESEARCH DESIGN
FIGURE 48
DATA OBTAINED FROM SECONDARY SOURCES
FIGURE 49
PRIMARY SOURCES
FIGURE 50
DATA OBTAINED FROM PRIMARY SOURCES
FIGURE 51
EXPERT INSIGHTS
FIGURE 52
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
FIGURE 53
BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)
FIGURE 54
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 55
SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 56
REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
FIGURE 57
REVENUE ANALYSIS OF TOP 5 COMPANIES: VETERINARY POC DIAGNOSTICS MARKET (2024)
FIGURE 58
VETERINARY POC DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
FIGURE 59
IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY POC DIAGNOSTICS MARKET (2026–2031)
FIGURE 60
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 61
TOP-DOWN APPROACH
FIGURE 62
BOTTOM-UP APPROACH
FIGURE 63
MARKET DATA TRIANGULATION METHODOLOGY
Methodology
This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.
Secondary Research
This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; and white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary PoC diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.
Primary Research
In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary PoC diagnostics market. Primary sources from the demand side include small and large animal veterinarians, veterinary clinic and hospital owners, managers of livestock farms and dairy operations, directors of veterinary diagnostic laboratories, officials from government animal health and regulatory agencies, and procurement and purchasing teams from veterinary clinics, hospitals, and farm operations.
A breakdown of the primary respondents is provided below:
Breakdown Of Primary Interviews: Supply-Side Participants, By Company Type, Designation, And Region
Note: C-level executives include CEOs, COOs, CTOs, and VPs.
Other designations include sales, marketing, and product managers.
Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the veterinary PoC diagnostics market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.
Veterinary PoC Diagnostics Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Market Definition
The veterinary PoC diagnostics market comprises products and technologies used for rapid, on-site diagnosis of diseases and health conditions in animals, enabling immediate clinical decision-making without reliance on centralized laboratories. The market includes consumables (such as test kits, cartridges, strips, and reagents) and instruments (including portable analyzers and handheld diagnostic devices) and covers key technologies such as molecular diagnostics (PCR-based, isothermal amplification, and CRISPR-based methods), immunodiagnostics, and other techniques, including clinical chemistry and hematology. It serves both companion animals (dogs, cats, horses, and others) and livestock (cattle, pigs, poultry, and others), with applications spanning infectious disease detection, routine health monitoring, and preventive care across veterinary clinics, farms, and field settings.
Key Stakeholders
- Veterinary PoC diagnostic kit manufacturers
- Molecular diagnostic technology providers & PoC instrument manufacturers
- Reagent & consumable suppliers
- Veterinary clinics & hospitals
- Livestock farms, dairy farms & integrated animal production companies
- Government animal health authorities & surveillance agencies
- Veterinary diagnostic laboratories
- Veterinarians & field-based animal health service providers
- Academic & veterinary research institutions
- Contract manufacturers & OEM partners
- Distributors & regional channel partners
- Market research & consulting firms
- Investors & venture capital firms
Report Objectives
- To define, describe, segment, and forecast the veterinary PoC diagnostics market by product, technology, animal type, and region, in terms of value
- To define, describe, segment, and forecast the veterinary PoC diagnostics market by product and region, in terms of volume
- To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall veterinary PoC diagnostics market
- To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies2
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the veterinary PoC diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the veterinary PoC diagnostics market and comprehensively analyze their core competencies and market shares
- To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships
1. Micromarkets are defined as the further segments and subsegments of the veterinary PoC diagnostics market included in the report.
2. Core competencies of companies are captured in terms of the key developments and strategies adopted by them to sustain their market positions.
Available customizations:
With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of Rest of Europe veterinary PoC diagnostics market into Austria, Finland, Switzerland, and other countries
- Further breakdown of Rest of Latin America veterinary PoC diagnostics market into Colombia, Chile, and other countries
Competitive Landscape Assessment
Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary PoC diagnostics market
- Competitive leadership mapping for established players in the US
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Company
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Company
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnostics
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Previous Next